Multinational companies operating in China have been forced to accelerate reviews of their internal compliance and staff training practices, after accusations of criminal activity against the former head of GlaxoSmithKline’s China unit sent shockwaves through the foreign business community.
葛兰素史克(GlaxoSmithKline)manbetx3.0 公司前负责人被指控存在犯罪行为，在manbetx3.0 外企圈内引发了轩然大波。在华运营的跨国公司被迫加快了对内部合规及人员培训措施的审查。
您已阅读10%（376字），剩余90%（3212字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。